Connect with others who understand.

Sign up Log in
Resources
About MyLungCancerTeam
Powered By
See answer
LUNG CANCER
NEWS

Are People With Lung Cancer Eligible for Moderna and Johnson & Johnson Booster Shots?

Written by Alison Channon
Posted on October 25, 2021

  • People with lung cancer may be eligible for additional doses of the Pfizer and Moderna COVID-19 vaccines, either 28 days after their second dose if they are immunocompromised or six months after their second dose as a booster.
  • All adults who received the Johnson & Johnson vaccine are eligible for a booster shot regardless of health status.
  • Health agencies have also approved “mix and match” boosters, meaning a person may receive initial doses of one type of COVID-19 vaccine and a booster of another.

The Centers for Disease for Control and Prevention (CDC) released recommendations for Moderna and Johnson & Johnson COVID-19 vaccination boosters on Oct. 21. Based on the new recommendations, adults with lung cancer who received the Moderna vaccine are likely eligible for a booster, even if not considered immunocompromised. All adults who received the Johnson & Johnson vaccine are eligible for a booster shot regardless of health status or other factors. Additionally, the CDC and U.S. Food and Drug Administration (FDA) have approved mix and match boosters, which allow people to receive initial doses of one type of COVID-19 vaccine and a booster of another.

Additional Vaccine Doses for People With Lung Cancer

An additional dose of the Pfizer or Moderna vaccine 28 days following the second dose may be recommended for those who did not develop an adequate immune response after the two-dose vaccination series.

The FDA amended the Pfizer and Moderna COVID-19 vaccines’ emergency use authorizations on Aug. 12 to allow a third vaccine dose 28 days after the second dose for certain immunocompromised individuals. Individuals defined as immunocompromised include people in cancer treatment, people who received a stem cell transplant in the last two years, people who are organ donor recipients and taking immunosuppressive drugs, people taking high-dose steroids or other immunosuppressive drugs, as well as those with certain other health conditions.

Booster Shot Eligibility

A COVID-19 vaccine booster is administered when someone developed adequate immunity after the initial vaccine dose or doses, but that immunity has decreased over time. If you have lung cancer or a history of lung cancer but are not considered immunocompromised, you are most likely eligible for a booster shot.

Moderna and Pfizer Eligibility

The following groups are now eligible for a booster shot at least six months after their second dose of the Moderna COVID-19 vaccine:

  • People over 65
  • People over 18 who have underlying medical conditions
  • People over 18 who live in long-term care facilities
  • People over 18 who live or work in high-risk settings (such as front-line workers or people who are incarcerated)

The FDA and CDC approved booster shots of the Pfizer vaccine for the same groups in September.

Cancer is included in the CDC’s list of underlying medical conditions that would make someone eligible for a Moderna or Pfizer booster six months after their second dose. The CDC website states, “Having cancer can make you more likely to get severely ill from COVID-19. Treatments for many types of cancer can weaken your body’s ability to fight off disease. At this time, based on available studies, having a history of cancer may increase your risk.”

The list of underlying medical conditions also includes conditions that can co-occur or precede lung cancer, including chronic lung disease, diabetes, heart conditions, and smoking or a smoking history.

Johnson & Johnson Eligibility

All adults over 18 who received the single-dose Johnson & Johnson COVID-19 vaccine are eligible for a booster shot at least two months after receiving their shot. The CDC recommendations were released after the FDA amended the emergency use authorizations for the Moderna and Johnson & Johnson COVID-19 vaccines to allow for booster doses.

Mix and Match Boosters

The FDA and CDC have authorized mix and match booster doses for the three COVID-19 vaccines available in the United States. This means that you can receive a booster dose of a different vaccine from your original vaccine. For example, any adult over 18 who received the Johnson & Johnson vaccine can receive a booster dose of the Pfizer, Moderna, or Johnson & Johnson vaccines at least two months after receiving their shot. Those who have received the Pfizer or Moderna vaccines and are eligible for a booster may receive it from any of the three companies six months after their second dose.

Talk to your doctor if you have questions about your eligibility for an additional COVID-19 vaccine dose.

Posted on October 25, 2021

A MyLungCancerTeam Member

I got my 3rd booster last Friday & my flu shot. I had nothing negative with getting at the same time. The Pfizer was thicker & hurt a little going in. My arm was a little sore when I tried to raise it… read more

September 29, 2022
All updates must be accompanied by text or a picture.

We'd love to hear from you! Please share your name and email to post and read comments.

You'll also get the latest articles directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy
All updates must be accompanied by text or a picture.

Subscribe now to ask your question, get answers, and stay up to date on the latest articles.

Get updates directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy
Alison Channon has nearly a decade of experience writing about chronic health conditions, mental health, and women's health. Learn more about her here.

Related Articles

Shared decision-making with your oncologist and care team can lead to better treatment outcomes ...

Newly Diagnosed With Advanced NSCLC: 4 Ways To Prepare

Shared decision-making with your oncologist and care team can lead to better treatment outcomes ...
After a lung cancer diagnosis, you might wonder how other health conditions or medications may af...

GLP-1 Drugs and Lung Cancer: Are They Safe To Take?

After a lung cancer diagnosis, you might wonder how other health conditions or medications may af...
Many people with lung cancer struggle to get a good night’s sleep.

Night Sweats and Lung Cancer: 3 Causes and 4 Tips for Relief

Many people with lung cancer struggle to get a good night’s sleep.
Inspirational cancer survivor stories may seem everywhere — in movies, books, magazines, and righ...

Are You Inspired by Lung Cancer Survivor Stories?

Inspirational cancer survivor stories may seem everywhere — in movies, books, magazines, and righ...
Being diagnosed with lung cancer means taking extra care of your health. Physical activity is a c...

What To Know About Exercising With Lung Cancer

Being diagnosed with lung cancer means taking extra care of your health. Physical activity is a c...
U.S. military veterans have an estimated 25 percent higher risk of developing lung cancer than pe...

VA Disability Rating for Lung Cancer: What To Know

U.S. military veterans have an estimated 25 percent higher risk of developing lung cancer than pe...

Recent Articles

The U.S. Food and Drug Administration (FDA) has approved a new injectable version of atezolizumab...

FDA Approves Time-Saving Injectable for Lung Cancer

The U.S. Food and Drug Administration (FDA) has approved a new injectable version of atezolizumab...
Did you know that the “sunshine vitamin” might play a role in lung health and cancer prevention? ...

Vitamin D and Lung Cancer: Can It Help or Hurt?

Did you know that the “sunshine vitamin” might play a role in lung health and cancer prevention? ...
Before you begin treatment for non-small cell lung cancer (NSCLC), you may have many questions an...

NSCLC Treatment Options: First-Line Treatments and Beyond

Before you begin treatment for non-small cell lung cancer (NSCLC), you may have many questions an...
The U.S. Food and Drug Administration (FDA) has approved Optune Lua, a portable device that deliv...

Wearable Device Approved To Treat Advanced NSCLC

The U.S. Food and Drug Administration (FDA) has approved Optune Lua, a portable device that deliv...
Treatment options for lung cancer may include surgery, chemotherapy, radiation therapy, targeted ...

Lung Cancer Treatment Options

Treatment options for lung cancer may include surgery, chemotherapy, radiation therapy, targeted ...
Lung cancer is tricky. Many people don’t realize they have it until it’s advanced because symptom...

Symptoms of Lung Cancer

Lung cancer is tricky. Many people don’t realize they have it until it’s advanced because symptom...
Translation missing: lgc.site_noun_short News

Thank you for subscribing!

Become a member to get even more: